Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsReceivablesReceivables - NetRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Addex Therapeutics (ADXN) Receivables - Other (2022 - 2024)

Historic Receivables - Other for Addex Therapeutics (ADXN) over the last 3 years, with Q4 2024 value amounting to $9094.5.

  • Addex Therapeutics' Receivables - Other fell 8027.94% to $9094.5 in Q4 2024 from the same period last year, while for Dec 2024 it was $9094.5, marking a year-over-year decrease of 8027.94%. This contributed to the annual value of $9056.1 for FY2024, which is 8011.73% down from last year.
  • According to the latest figures from Q4 2024, Addex Therapeutics' Receivables - Other is $9094.5, which was down 8027.94% from $42130.9 recorded in Q3 2024.
  • In the past 5 years, Addex Therapeutics' Receivables - Other registered a high of $274291.4 during Q2 2023, and its lowest value of $9094.5 during Q4 2024.
  • For the 3-year period, Addex Therapeutics' Receivables - Other averaged around $117145.9, with its median value being $102906.1 (2022).
  • Per our database at Business Quant, Addex Therapeutics' Receivables - Other soared by 23759.14% in 2023 and then plummeted by 8769.6% in 2024.
  • Addex Therapeutics' Receivables - Other (Quarter) stood at $124562.6 in 2022, then tumbled by 62.98% to $46116.7 in 2023, then tumbled by 80.28% to $9094.5 in 2024.
  • Its Receivables - Other was $9094.5 in Q4 2024, compared to $42130.9 in Q3 2024 and $33748.8 in Q2 2024.